Sangamo Therapeutics Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Good morning, everyone. My name is Gena Wang. I'm Senior Biotech Analyst at Barclays. Welcome to our Second Virtual Global Healthcare Conference. First, I wish everyone stay healthy and I would like to thank all the participants, investors, companies and especially our event team and corporate access team who made this virtual healthcare conference possible.
With that, I'd like to introduce our next presenting company Sangamo. With us we have Sandy Macrae, Chief Executive Officer; and also we have Mark McClung, our Chief Business Officer.
With that, I hand over to you, Sandy.
Thank you, Gena. So can I share my screen and I'll put it on full screen. So it's a pleasure to speak to and give you a short summary of Sangamo. So as always, I would direct you to our forward-looking statements.
Sangamo is a fascinating company and we believe that genomic medicines will change the fate of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
